SDIX LLC is a wholly owned subsidiary of OriGene Technologies, specializing in high quality, large-scale cGMP monoclonal and polyclonal antibody production. For over 25 years, SDIX has been a leading immuno-solutions company, developing results-oriented and innovative antibody-based solutions that enable customers, world-wide, to meet high performance diagnostic and commercialization objectives. All our sites are ISO 13485:2016 certified and FDA registered as well as USDA/APHIS approved for collection and export of blood products to the EU. In addition to our antibody production services we offer a wide variety of IVD critical reagents such as antibodies to Troponin I, Strep A, Strep B, Albumin, AGP, ApoA1, ApoB, B2M, CER, C3, C4, CRP, HPT, IgA, IgG, IgM, IgE, Red Blood Cells, TRF as well as Human Serum Calibrators. For IHC applications, we offer over 40 CE-marked IHC antibodies.